• Je něco špatně v tomto záznamu ?

Variants in IGLL1 cause a broad phenotype from agammaglobulinemia to transient hypogammaglobulinemia

M. Soomann, V. Bily, M. Elgizouli, D. Kraemer, G. Akgül, H. von Bernuth, M. Bloomfield, N. Brodszki, F. Candotti, E. Förster-Waldl, T. Freiberger, M. Giżewska, A. Klocperk, U. Kölsch, KE. Nichols, R. Krüger, N. Oak, M. Pac, S. Prader, K....

. 2024 ; 154 (5) : 1313-1324.e7. [pub] 20240813

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003701

BACKGROUND: Agammaglobulinemia due to variants in IGLL1 has traditionally been considered an exceedingly rare form of severe B-cell deficiency, with only 8 documented cases in the literature. Surprisingly, the first agammaglobulinemic patient identified by newborn screening (NBS) through quantification of kappa-deleting recombination excision circles harbored variants in IGLL1. OBJECTIVE: We comprehensively reviewed clinical and immunologic findings of patients with B-cell deficiency attributed to variants in IGLL1. METHODS: NBS programs reporting the use of kappa-deleting recombination excision circle assays, the European Society for Immunodeficiencies Registry, and authors of published reports featuring patients with B-cell deficiency linked to IGLL1 variants were contacted. Only patients with (likely) pathogenic variants, reduced CD19+ counts, and no alternative diagnosis were included. RESULTS: The study included 13 patients identified through NBS, 2 clinically diagnosed patients, and 2 asymptomatic siblings. All had severely reduced CD19+ B cells (< 0.1 × 109/L) at first evaluation, yet subsequent follow-up assessments indicated residual immunoglobulin production. Specific antibody responses to vaccine antigens varied, with a predominant reduction observed during infancy. Clinical outcomes were favorable with IgG substitution. Two patients successfully discontinued substitution therapy without developing susceptibility to infections and while maintaining immunoglobulin levels. The pooled incidence of homozygous or compound heterozygous pathogenic IGLL1 variants identified by NBS in Austria, Czechia, and Switzerland was 1.3:100,000, almost double of X-linked agammaglobulinemia. CONCLUSION: B-cell deficiency resulting from IGLL1 variants appears to be more prevalent than initially believed. Despite markedly low B-cell counts, the clinical course in some patients may be milder than reported in the literature so far.

Berlin Institute of Health at Charité Universitätsmedizin Berlin Berlin Germany

Charité Universitätsmedizin Berlin corporate member of Freie Universität Berlin Humboldt Universität zu Berlin and Berlin Institute of Health Berlin Brandenburg Center for Regenerative Therapies Berlin Germany

Charité Universitätsmedizin Berlin corporate member of Freie Universität Berlin Humboldt Universität zu Berlin Department of Pediatric Respiratory Medicine Immunology and Critical Care Medicine University Hospital Center Berlin Germany

Childrens' Hospital Skåne University Hospital Lund Sweden

Department of Allergy and Immunology The Children's Hospital at Westmead Sydney Australia

Department of Clinical Genetics University Hospital Copenhagen Copenhagen Denmark

Department of Clinical Medicine Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

Department of Human Genetics Labor Berlin Charité Vivantes GmbH Berlin Germany

Department of Immunology 2nd Faculty of Medicine Charles University and University Hospital in Motol Prague Czechia

Department of Immunology Labor Berlin Charité Vivantes GmbH Berlin Germany

Department of Immunology The Children's Memorial Health Institute Warsaw Poland

Department of Oncology St Jude Children's Research Hospital Memphis Tenn

Department of Paediatrics and Adolescent Medicine Division of Neonatology Neuropaediatrics and Paediatric Intensive Care and Center for Congenital Immunodeficiencies and Jeffrey Modell Diagnostic and Research Center Medical University of Vienna Vienna Austria

Department of Pediatrics and Adolescent Medicine Austrian Newborn Screening Clinical Division of Pediatric Pulmonology Allergology and Endocrinology Comprehensive Center for Pediatrics Medical University of Vienna Vienna Austria

Department of Pediatrics and Adolescent Medicine Rigshospitalet Copenhagen Denmark

Department of Pediatrics Endocrinology Diabetology Metabolic Diseases and Cardiology of the Developmental Age Pomeranian Medical University in Szczecin Szczecin Poland

Department of Rheumatology and Immunology Hannover Medical University and Hannover Medical School Hannover Germany

Division of Immunology and Allergy Lausanne University Hospital and University of Lausanne Lausanne Switzerland

Division of Immunology and the Children's Research Center University Children's Hospital Zurich University of Zurich Zurich Switzerland

Institute of Medical Genetics University of Zurich Zurich Switzerland

Molecular Genetics Laboratory Centre for Cardiovascular Surgery and Transplantation Brno and Medical Faculty Masaryk University Brno Czechia

Unit of Pediatric Immunology Allergology and Rheumatology Department of Woman Mother Child Lausanne University Hospital and University of Lausanne Lausanne Switzerland

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003701
003      
CZ-PrNML
005      
20250206104627.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jaci.2024.08.002 $2 doi
035    __
$a (PubMed)39147326
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Soomann, Maarja $u Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: Maarja.Soomann@kispi.uzh.ch
245    10
$a Variants in IGLL1 cause a broad phenotype from agammaglobulinemia to transient hypogammaglobulinemia / $c M. Soomann, V. Bily, M. Elgizouli, D. Kraemer, G. Akgül, H. von Bernuth, M. Bloomfield, N. Brodszki, F. Candotti, E. Förster-Waldl, T. Freiberger, M. Giżewska, A. Klocperk, U. Kölsch, KE. Nichols, R. Krüger, N. Oak, M. Pac, S. Prader, K. Schmiegelow, A. Šedivá, G. Sogkas, A. Stittrich, UK. Stoltze, K. Theodoropoulou, K. Wadt, M. Wong, M. Zeyda, J. Pachlopnik Schmid, J. Trück
520    9_
$a BACKGROUND: Agammaglobulinemia due to variants in IGLL1 has traditionally been considered an exceedingly rare form of severe B-cell deficiency, with only 8 documented cases in the literature. Surprisingly, the first agammaglobulinemic patient identified by newborn screening (NBS) through quantification of kappa-deleting recombination excision circles harbored variants in IGLL1. OBJECTIVE: We comprehensively reviewed clinical and immunologic findings of patients with B-cell deficiency attributed to variants in IGLL1. METHODS: NBS programs reporting the use of kappa-deleting recombination excision circle assays, the European Society for Immunodeficiencies Registry, and authors of published reports featuring patients with B-cell deficiency linked to IGLL1 variants were contacted. Only patients with (likely) pathogenic variants, reduced CD19+ counts, and no alternative diagnosis were included. RESULTS: The study included 13 patients identified through NBS, 2 clinically diagnosed patients, and 2 asymptomatic siblings. All had severely reduced CD19+ B cells (< 0.1 × 109/L) at first evaluation, yet subsequent follow-up assessments indicated residual immunoglobulin production. Specific antibody responses to vaccine antigens varied, with a predominant reduction observed during infancy. Clinical outcomes were favorable with IgG substitution. Two patients successfully discontinued substitution therapy without developing susceptibility to infections and while maintaining immunoglobulin levels. The pooled incidence of homozygous or compound heterozygous pathogenic IGLL1 variants identified by NBS in Austria, Czechia, and Switzerland was 1.3:100,000, almost double of X-linked agammaglobulinemia. CONCLUSION: B-cell deficiency resulting from IGLL1 variants appears to be more prevalent than initially believed. Despite markedly low B-cell counts, the clinical course in some patients may be milder than reported in the literature so far.
650    _2
$a lidé $7 D006801
650    12
$a agamaglobulinemie $x genetika $x imunologie $x diagnóza $7 D000361
650    _2
$a mužské pohlaví $7 D008297
650    12
$a fenotyp $7 D010641
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a novorozenec $7 D007231
650    _2
$a B-lymfocyty $x imunologie $7 D001402
650    _2
$a kojenec $7 D007223
650    _2
$a předškolní dítě $7 D002675
650    _2
$a dítě $7 D002648
650    _2
$a mladiství $7 D000293
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Bily, Viktor $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation Brno and Medical Faculty, Masaryk University, Brno, Czechia
700    1_
$a Elgizouli, Magdeldin $u Institute of Medical Genetics, University of Zurich, Zurich, Switzerland
700    1_
$a Kraemer, Dennis $u Institute of Medical Genetics, University of Zurich, Zurich, Switzerland
700    1_
$a Akgül, Gülfirde $u Institute of Medical Genetics, University of Zurich, Zurich, Switzerland
700    1_
$a von Bernuth, Horst $u Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Pediatric Respiratory Medicine, Immunology, and Critical Care Medicine, University Hospital Center, Berlin, Germany; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany; Department of Immunology, Labor Berlin-Charité Vivantes GmbH, Berlin, Germany; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany
700    1_
$a Bloomfield, Markéta $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czechia
700    1_
$a Brodszki, Nicholas $u Childrens' Hospital, Skåne University Hospital, Lund, Sweden
700    1_
$a Candotti, Fabio $u Division of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
700    1_
$a Förster-Waldl, Elisabeth $u Department of Paediatrics and Adolescent Medicine, Division of Neonatology, Neuropaediatrics, and Paediatric Intensive Care and Center for Congenital Immunodeficiencies and Jeffrey Modell Diagnostic & Research Center, Medical University of Vienna, Vienna, Austria
700    1_
$a Freiberger, Tomas $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation Brno and Medical Faculty, Masaryk University, Brno, Czechia
700    1_
$a Giżewska, Maria $u Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases, and Cardiology of the Developmental Age, Pomeranian Medical University in Szczecin, Szczecin, Poland
700    1_
$a Klocperk, Adam $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czechia
700    1_
$a Kölsch, Uwe $u Department of Immunology, Labor Berlin-Charité Vivantes GmbH, Berlin, Germany
700    1_
$a Nichols, Kim E $u Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn
700    1_
$a Krüger, Renate $u Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Pediatric Respiratory Medicine, Immunology, and Critical Care Medicine, University Hospital Center, Berlin, Germany
700    1_
$a Oak, Ninad $u Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn
700    1_
$a Pac, Małgorzata $u Department of Immunology, The Children's Memorial Health Institute, Warsaw, Poland
700    1_
$a Prader, Seraina $u Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland
700    1_
$a Schmiegelow, Kjeld $u Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark
700    1_
$a Šedivá, Anna $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czechia
700    1_
$a Sogkas, Georgios $u Department of Rheumatology and Immunology, Hannover Medical University, and Hannover Medical School, Hannover, Germany
700    1_
$a Stittrich, Anna $u Department of Human Genetics, Labor Berlin-Charité Vivantes GmbH, Berlin, Germany
700    1_
$a Stoltze, Ulrik Kristoffer $u Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark
700    1_
$a Theodoropoulou, Katerina $u Unit of Pediatric Immunology, Allergology and Rheumatology, Department of Woman, Mother, Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
700    1_
$a Wadt, Karin $u Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Genetics, University Hospital Copenhagen, Copenhagen, Denmark
700    1_
$a Wong, Melanie $u Department of Allergy and Immunology, The Children's Hospital at Westmead, Sydney, Australia
700    1_
$a Zeyda, Maximillian $u Department of Pediatrics and Adolescent Medicine, Austrian Newborn Screening, Clinical Division of Pediatric Pulmonology, Allergology and Endocrinology, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria
700    1_
$a Pachlopnik Schmid, Jana $u Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland
700    1_
$a Trück, Johannes $u Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland
773    0_
$w MED00002505 $t Journal of allergy and clinical immunology $x 1097-6825 $g Roč. 154, č. 5 (2024), s. 1313-1324.e7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39147326 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104623 $b ABA008
999    __
$a ok $b bmc $g 2263456 $s 1239708
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 154 $c 5 $d 1313-1324.e7 $e 20240813 $i 1097-6825 $m Journal of allergy and clinical immunology $n J Allergy Clin Immunol $x MED00002505
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...